CULLEN MICHAEL T. (Exec. Chairman, Pres. & CEO) reported 1 transaction at PANBELA THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/2/2019ACC: 0001437749-19-013383
DirectorOfficer10% Owner· Exec. Chairman, Pres. & CEO
Since Dec 2018
-24.50K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
10.49K acquired · 35K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+10.49K
Price / share
—
Trade value
—
% of position
6.7%
6/30/2019
157.50K→168K
Total
Net shares
+10.49K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2019 | C · Conversion | +10.49K | — | — | 6.7% | 157.50K | 168K |
| Total | +10.49K | $0.00 | ||||||
Derivative Transactions1
Convertible Promissory Note
Direct
Converts to
Common Stock
10.49K shares
Shares
−35K
Strike price
3.50
Held after
0.00
Exercisable
—
6/30/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Convertible Promissory Note Direct | Common Stock10.49K shares | 6/30/2019 | C · Conversion | −35K | 3.50 | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned194.58K
Total
194.58K indirect194.58K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 194.58K | Indirect |
| Total | 194.58K | 194.58K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported